| Alicia Hills, LCSW | |
|
202 E 800 S Ste 105, Orem, UT 84058-6340 | |
| (385) 283-1032 | |
| Not Available |
| Full Name | Alicia Hills |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 202 E 800 S Ste 105, Orem, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003458001 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 62671163501 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Alicia Hills, LCSW 202 E 800 S Ste 105, Orem, UT 84058-6340 Ph: (385) 283-1032 | Alicia Hills, LCSW 202 E 800 S Ste 105, Orem, UT 84058-6340 Ph: (385) 283-1032 |
News Archive
A team of researchers from the Johns Hopkins Children's Center, Vanderbilt University and elsewhere have demonstrated that high blood pressure and anemia together put children with sickle cell disease (SCD) at serious danger for symptomless or so-called "silent" strokes, although either condition alone also signaled high risk.
In this interview with GlobalPost's John Donnelly, Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases at NIH, discusses "his perspective of the fight against AIDS at this moment, and how discoveries by scientists can now be best used."
Depomed, Inc. today announced that it has closed the acquisition of the U.S. rights to the NUCYNTA franchise from Janssen Pharmaceuticals, Inc. for $1.05 billion. The NUCYNTA franchise includes: NUCYNTA ER (tapentadol) extended release tablets indicated for the management of pain, including neuropathic pain associated with diabetic peripheral neuropathy (DPN), severe enough to require daily, around-the-clock, long-term opioid treatment; NUCYNTA (tapentadol), an immediate release version of tapentadol, for management of moderate to severe acute pain in adults; and NUCYNTA (tapentadol) oral solution, an approved oral form of tapentadol that has not been launched.
Veracyte, Inc., a molecular diagnostics company pioneering the emerging field of molecular cytology, and Genzyme, a Sanofi company, today announced that the New York State Department of Health has issued a license enabling Veracyte's Afirma Gene Expression Classifier to be offered to patients in the state.
› Verified 4 days ago
Katie Fishman, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 600 S Geneva Rd, Orem, UT 84059 Phone: 801-877-5300 | |
Morgan Oliphant, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1255 N 1200 W, Orem, UT 84057 Phone: 801-229-1181 | |
Rebecca Jane Mcnairy, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1125 W Center St, Orem, UT 84057 Phone: 801-903-5903 | |
Erin Elizabeth Vasquez, LCSW, RPT Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1255 N 1200 W, Orem, UT 84057 Phone: 801-229-1181 Fax: 801-229-2787 | |
Mr. Mark James Capell, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 313 E 1200 S, Suite 104, Orem, UT 84058 Phone: 801-377-1595 Fax: 801-377-1598 | |
Terry R Routt, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 570 E 1400 S, Orem, UT 84097 Phone: 801-426-6661 Fax: 801-426-6660 |